NIH-funded research R01 grant

How microRNAs control allergy and asthma

Official title: MicroRNA directed pathway discovery in allergy and asthma

Funded at University of California, San Francisco · NIH-11323869 · Data updated 2026-11-12

This work looks at tiny gene-regulating molecules called microRNAs to find molecular ways to reduce allergic inflammation in people with asthma.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 1, 2011
Project endFebruary 28, 2029
Funding year2026
Award (this year)$485,353
NIH project number5R01HL109102-15
Project IDNIH-11323869 on NIH RePORTER

Who could benefit from this research

Could help

People with allergic asthma—especially those with frequent flare-ups or evidence of Th2-driven disease—would be the most relevant candidates for future therapies from this work.

Less likely to help

People with non-allergic forms of asthma or airway disease driven by other mechanisms may be less likely to benefit.

What this research studies

Researchers are studying tiny molecules called microRNAs and long noncoding RNAs that help control immune cells involved in allergic asthma. They focus on the miR-15/16 family and the lncRNA MALAT1 to understand how these RNAs affect regulatory T cells (Tregs) that normally limit allergic inflammation. Using laboratory experiments that map RNA targets and manipulate these molecules in immune cells and model systems, they chart the molecular circuits that drive airway inflammation. The team hopes those circuits will point to new molecular targets for therapies to reduce allergic lung inflammation.

Why it matters

Potential benefit: If successful, the work could point to new treatments that restore Treg control and reduce allergic asthma symptoms.

How similar studies have gone: Previous laboratory studies support roles for miR-15/16 and MALAT1 in Treg function and allergy models, but translating these findings into human treatments remains experimental.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Ansel, Karl Mark — University of California, San Francisco
  • Study coordinator: Ansel, Karl Mark

Related research

Other NIH-funded projects on the same topics.

  • Childhood Allergy and the Neonatal Environment: Early Life Airways and Asthma

    A long-term study following newborns to age 5 to understand how early-life nose and airway biology, immune development, and the environment influence asthma risk.

    NIH research University of Wisconsin-Madison · Madison, United States · NIH-11430311

  • Role of a special interferon-responsive T cell in allergies and asthma

    A study explores a unique interferon-responsive T cell type that may influence allergies and asthma, aiming to understand why some people become allergic and how this T cell subset could affect airway inflammation.

    NIH research San Diego Biomedical Research Institute · San Diego, United States · NIH-11389644

  • Children's Allergy and Asthma Data Hub

    A national data hub will pool and harmonize child allergy and asthma cohort data to help researchers discover ways to prevent asthma in kids.

    NIH research University of Wisconsin-Madison · Madison, United States · NIH-11375082

  • Viral and Host Factors in Infant and Child Allergy and Asthma

    This grant explores why some babies and young children develop asthma by studying how viruses, environment, and airway cells interact from birth.

    NIH research Vanderbilt University Medical Center · Nashville, United States · NIH-11353460

  • Children's Allergy and Asthma Data Hub (CADRE)

    This project builds a shared data hub that combines many childhood allergy and asthma birth-study records so researchers can find early-life factors that change a child's risk of asthma.

    NIH research University of Wisconsin-Madison · Madison, United States · NIH-11345660

  • A newly discovered interferon-responsive immune cell linked to allergies and asthma

    Researchers are looking at whether a newly discovered interferon-responsive T cell helps protect people exposed to allergens from developing allergic reactions and asthma.

    NIH research San Diego Biomedical Research Institute · San Diego, United States · NIH-11159859

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.